Royer RE - Search Results

1

The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum.

Dando C, Schroeder ER, Hunsaker LA, Deck LM, Royer RE, Zhou X, Parmley SF, Vander Jagt DL. Dando C, et al. Among authors: royer re. Mol Biochem Parasitol. 2001 Nov;118(1):23-32. doi: 10.1016/s0166-6851(01)00360-7. Mol Biochem Parasitol. 2001. PMID: 11704270

2

Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum.

Gomez MS, Piper RC, Hunsaker LA, Royer RE, Deck LM, Makler MT, Vander Jagt DL. Gomez MS, et al. Among authors: royer re. Mol Biochem Parasitol. 1997 Dec 1;90(1):235-46. doi: 10.1016/s0166-6851(97)00140-0. Mol Biochem Parasitol. 1997. PMID: 9497046

3

Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4.

Yu Y, Deck JA, Hunsaker LA, Deck LM, Royer RE, Goldberg E, Vander Jagt DL. Yu Y, et al. Among authors: royer re. Biochem Pharmacol. 2001 Jul 1;62(1):81-9. doi: 10.1016/s0006-2952(01)00636-0. Biochem Pharmacol. 2001. PMID: 11377399

4

Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites.

Brown WM, Yowell CA, Hoard A, Vander Jagt TA, Hunsaker LA, Deck LM, Royer RE, Piper RC, Dame JB, Makler MT, Vander Jagt DL. Brown WM, et al. Among authors: royer re. Biochemistry. 2004 May 25;43(20):6219-29. doi: 10.1021/bi049892w. Biochemistry. 2004. PMID: 15147206

5

Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.

Deck LM, Royer RE, Chamblee BB, Hernandez VM, Malone RR, Torres JE, Hunsaker LA, Piper RC, Makler MT, Vander Jagt DL. Deck LM, et al. Among authors: royer re. J Med Chem. 1998 Sep 24;41(20):3879-87. doi: 10.1021/jm980334n. J Med Chem. 1998. PMID: 9748363

6

Gossypol and derivatives: a new class of aldose reductase inhibitors.

Deck LM, Vander Jagt DL, Royer RE. Deck LM, et al. Among authors: royer re. J Med Chem. 1991 Nov;34(11):3301-5. doi: 10.1021/jm00115a021. J Med Chem. 1991. PMID: 1956050

7

Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles.

Royer RE, Deck LM, Campos NM, Hunsaker LA, Vander Jagt DL. Royer RE, et al. J Med Chem. 1986 Sep;29(9):1799-801. doi: 10.1021/jm00159a043. J Med Chem. 1986. PMID: 3528492

8

Gossypol: prototype of inhibitors targeted to dinucleotide folds.

Vander Jagt DL, Deck LM, Royer RE. Vander Jagt DL, et al. Among authors: royer re. Curr Med Chem. 2000 Apr;7(4):479-98. doi: 10.2174/0929867003375119. Curr Med Chem. 2000. PMID: 10702620 Review.

9

Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol.

Royer RE, Mills RG, Deck LM, Mertz GJ, Vander Jagt DL. Royer RE, et al. Pharmacol Res. 1991 Dec;24(4):407-12. doi: 10.1016/1043-6618(91)90045-y. Pharmacol Res. 1991. PMID: 1805194

10

17-beta-Hydroxysteroid dehydrogenase type 1: computational design of active site inhibitors targeted to the Rossmann fold.

Brown WM, Metzger LE, Barlow JP, Hunsaker LA, Deck LM, Royer RE, Vander Jagt DL. Brown WM, et al. Among authors: royer re. Chem Biol Interact. 2003 Feb 1;143-144:481-91. doi: 10.1016/s0009-2797(02)00184-9. Chem Biol Interact. 2003. PMID: 12604234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters